Depletion of neutrophils or blocking SPIB–SPI1 interaction significantly suppresses glycolytic process, tumourigenesis, as well as aggressiveness of cancer cells, suggesting that SPIB/SPI1‐facilitated interplay of cancer cells and neutrophils may be a potential therapeutic target for cancers. This evidence concerns the gene SPI1 and cancer.